These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 624024)

  • 21. Pathogenesis and treatment of secondary hyperparathyroidism in chronic renal disease.
    Cannella G; Messa P
    Int J Artif Organs; 1999 Jan; 22(1):1-7. PubMed ID: 10098576
    [No Abstract]   [Full Text] [Related]  

  • 22. Secondary hyperparathyroidism in chronic renal failure. The clinical spectrum in uremia, during hemodialysis, and after renal transplantation.
    Massry SG; Coburn JW; Popovtzer MM; Shinaberger JH; Maxwell MH; Kleeman CR
    Arch Intern Med; 1969 Oct; 124(4):431-41. PubMed ID: 4901739
    [No Abstract]   [Full Text] [Related]  

  • 23. Beyond minerals and parathyroid hormone: role of active vitamin D in end-stage renal disease.
    Wolf M; Thadhani R
    Semin Dial; 2005; 18(4):302-6. PubMed ID: 16076353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hyperparathyroidism in chronic renal insufficiency].
    Labos I
    Med Arh; 1984; 38(4):171-5. PubMed ID: 6400965
    [No Abstract]   [Full Text] [Related]  

  • 25. The new treatments of hyperparathyroidism secondary to renal insufficiency.
    Fournier A; Drüeke T; Morinière P; Zingraff J; Boudailliez B; Achard JM
    Adv Nephrol Necker Hosp; 1992; 21():237-306. PubMed ID: 1566648
    [No Abstract]   [Full Text] [Related]  

  • 26. Does long term haemofiltration provoke secondary hyperparathyroidism?
    Schneider H; Streicher E; Schmidt-Gayk H; Bosnjakovic S
    Proc Eur Dial Transplant Assoc; 1978; 15():532-9. PubMed ID: 740684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vitamin D treatment in chronic kidney disease.
    Andress DL
    Semin Dial; 2005; 18(4):315-21. PubMed ID: 16076355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacotherapy and interventional treatments for secondary hyperparathyroidism: current therapy and future challenges.
    Komaba H; Shiizaki K; Fukagawa M
    Expert Opin Biol Ther; 2010 Dec; 10(12):1729-42. PubMed ID: 21058933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Secondary hyperparathyroidism in chronic renal disease.
    Potts JT; Reita RE; Deftos LJ; Kaye MB; Richardson JA; Buckle RM; Aurbach GD
    Arch Intern Med; 1969 Oct; 124(4):408-12. PubMed ID: 5387817
    [No Abstract]   [Full Text] [Related]  

  • 30. The treatment of metabolic bone disease in patients on peritoneal dialysis.
    Armstrong A; Cunningham J
    Kidney Int Suppl; 1994 Dec; 48():S51-7. PubMed ID: 7700042
    [No Abstract]   [Full Text] [Related]  

  • 31. Surgical treatment of secondary hyperparathyroidism.
    Brunt LM; Wells SA
    Ann Chir Gynaecol; 1983; 72(3):139-45. PubMed ID: 6354046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Indications for parathyroidectomy in advanced renal disease.
    Buck BA; Robertson RD
    Surg Gynecol Obstet; 1971 Aug; 133(2):218-24. PubMed ID: 4935588
    [No Abstract]   [Full Text] [Related]  

  • 33. [Secondary hyperparathyroidism].
    Imanishi Y; Inaba M
    Nihon Rinsho; 2006 Jun; Suppl 2():31-6. PubMed ID: 16817344
    [No Abstract]   [Full Text] [Related]  

  • 34. Active vitamin D agents and refractory hyperparathyroidism in dialysis patients.
    Basile C; Lomonte C
    Kidney Int; 2005 Jul; 68(1):410; author reply 410-1. PubMed ID: 15954938
    [No Abstract]   [Full Text] [Related]  

  • 35. Medical treatment in primary and secondary hyperparathyroidism.
    Coburn JW; Brickman AS; Massry SG
    Semin Drug Treat; 1972; 2(1):117-35. PubMed ID: 4261783
    [No Abstract]   [Full Text] [Related]  

  • 36. Prevention and treatment of progressive secondary hyperparathyroidism in advanced renal failure.
    Johnson WJ; Goldsmith RS; Arnaud CD
    Med Clin North Am; 1972 Jul; 56(4):961-75. PubMed ID: 4556132
    [No Abstract]   [Full Text] [Related]  

  • 37. [Progression of hyperparathyroidism during hemodialysis. Response to conservative treatment].
    García de Vinuesa S; Luño J; González C; Resano M; Allés A; Olivas E; Barril G; Valderrábano F
    Rev Clin Esp; 1982 Feb; 164(3):163-7. PubMed ID: 6896386
    [No Abstract]   [Full Text] [Related]  

  • 38. Medical management of renal hyperparathyroidism. Pulse treatment with vitamin D metabolites or not?
    Reichel H
    Nephrol Dial Transplant; 1994; 9(10):1368-70. PubMed ID: 7816246
    [No Abstract]   [Full Text] [Related]  

  • 39. New developments in hyperphosphatemia management.
    Slatopolsky E
    J Am Soc Nephrol; 2003 Sep; 14(9 Suppl 4):S297-9. PubMed ID: 12939384
    [No Abstract]   [Full Text] [Related]  

  • 40. [On the therapy of hyperparathyroidism in association with progressive renal insufficiency].
    Opitz A; Schaefer K; Koch HU; Höffler D
    Dtsch Med Wochenschr; 1968 May; 93(20):1003-5. PubMed ID: 5648075
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.